Related Experiment Video

Updated: Jun 15, 2026

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
05:34

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

Published on: April 4, 2025

A basic approach to CKD

Eric E Simon1, L Lee Hamm

  • 1Department of Medicine, Tulane University School of Medicine, New Orleans, Louisiana 70112, USA.

Kidney International
|March 13, 2010
PubMed

Insights

Sodium citrate may help reduce kidney damage in chronic kidney disease (CKD) patients not on dialysis. This treatment also lowers urinary endothelin, potentially slowing CKD progression.

Area of Science:

  • Nephrology
  • Internal Medicine
  • Biochemistry

Background:

  • Metabolic acidosis is a common complication in chronic kidney disease (CKD).
  • Acidosis negatively impacts bone health, nutrition, and overall metabolism in CKD patients.
  • Acidosis may accelerate CKD progression through various mechanisms.

Purpose of the Study:

  • To investigate the potential of sodium citrate in ameliorating kidney injury in non-dialysis CKD patients.
  • To explore the effect of sodium citrate treatment on urinary endothelin levels in humans.
  • To elucidate the role of endothelin in acidosis-induced CKD progression.

Main Methods:

  • Clinical study involving CKD patients not on dialysis.
  • Administration of sodium citrate as a therapeutic intervention.
  • Measurement of urinary endothelin levels before and after treatment.

Main Results:

  • Sodium citrate demonstrated a potential to ameliorate kidney injury in the studied CKD population.
  • Treatment with sodium citrate led to a significant reduction in urinary endothelin levels.
  • Increased endothelin levels may be implicated in the progression of CKD driven by acidosis.

Conclusions:

  • Sodium citrate may offer a therapeutic benefit for kidney health in CKD patients.
  • The reduction in urinary endothelin suggests a potential mechanism by which sodium citrate acts.
  • Targeting endothelin pathways could be a strategy to mitigate acidosis-related CKD progression.

More Related Videos

Assessment of Vascular Function in Patients With Chronic Kidney Disease08:50

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Published on: June 16, 2014

Mouse Model of Acute to Chronic Kidney Disease Transition Induced by Renal Ischemia/Reperfusion Injury07:02

Mouse Model of Acute to Chronic Kidney Disease Transition Induced by Renal Ischemia/Reperfusion Injury

Published on: February 10, 2026

Related Concept Videos

Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area. This equation is...